Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cleveland BioLabs reports positive results from mouse study of CBLB-612

Dec. 20, 2007

Phase I studies of AVE-9633, AVE-1642 reported

Dec. 20, 2007

Novel oncolytic drugs revealed in recent patent literature

Dec. 20, 2007

Philippine Bureau of Food and Drugs grants product registration for Epeius' Rexin-G

Dec. 19, 2007

Cell Therapeutics to submit MAA for Xyotax in the first quarter of 2008 ahead of schedule

Dec. 19, 2007

Avastin approved in Europe for first-line treatment of advanced RCC

Dec. 19, 2007

FDA approves supplemental indication for Genzyme's Thyrogen in thyroid cancer ablation

Dec. 19, 2007

Dual Akt/p70S6K inhibitor effective against multiple myeloma in vitro

Dec. 19, 2007

DCC-2036 shows preclinical antileukemic activity against drug-resistant CML

Dec. 19, 2007

Increased survival in mouse models of multiple myeloma with Prolexys' new compound

Dec. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...